Literature DB >> 17320163

The retinoblastoma binding protein RBP2 is an H3K4 demethylase.

Robert J Klose1, Qin Yan, Zuzana Tothova, Kenichi Yamane, Hediye Erdjument-Bromage, Paul Tempst, D Gary Gilliland, Yi Zhang, William G Kaelin.   

Abstract

Changes in histone methylation status regulate chromatin structure and DNA-dependent processes such as transcription. Recent studies indicate that, analogous to other histone modifications, histone methylation is reversible. Retinoblastoma binding protein 2 (RBP2), a nuclear protein implicated in the regulation of transcription and differentiation by the retinoblastoma tumor suppressor protein, contains a JmjC domain recently defined as a histone demethylase signature motif. Here we report that RBP2 is a demethylase that specifically catalyzes demethylation on H3K4, whose methylation is normally associated with transcriptionally active genes. RBP2-/- mouse cells displayed enhanced transcription of certain cytokine genes, which, in the case of SDF1, was associated with increased H3K4 trimethylation. Furthermore, RBP2 specifically demethylated H3K4 in biochemical and cell-based assays. These studies provide mechanistic insights into transcriptional regulation by RBP2 and provide the first example of a mammalian enzyme capable of erasing trimethylated H3K4.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17320163     DOI: 10.1016/j.cell.2007.02.013

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  203 in total

1.  The JmjN domain of Jhd2 is important for its protein stability, and the plant homeodomain (PHD) finger mediates its chromatin association independent of H3K4 methylation.

Authors:  Fu Huang; Mahesh B Chandrasekharan; Yi-Chun Chen; Srividya Bhaskara; Scott W Hiebert; Zu-Wen Sun
Journal:  J Biol Chem       Date:  2010-06-09       Impact factor: 5.157

Review 2.  Molecular mechanisms and potential functions of histone demethylases.

Authors:  Susanne Marije Kooistra; Kristian Helin
Journal:  Nat Rev Mol Cell Biol       Date:  2012-04-04       Impact factor: 94.444

3.  Activity of a C-terminal plant homeodomain (PHD) of Msc1 is essential for function.

Authors:  Xinxing Qiu; Barbara E Dul; Nancy C Walworth
Journal:  J Biol Chem       Date:  2010-09-21       Impact factor: 5.157

4.  Histone demethylase KDM5A is an integral part of the core Notch-RBP-J repressor complex.

Authors:  Robert Liefke; Franz Oswald; Cristobal Alvarado; Dolores Ferres-Marco; Gerhard Mittler; Patrick Rodriguez; Maria Dominguez; Tilman Borggrefe
Journal:  Genes Dev       Date:  2010-03-15       Impact factor: 11.361

5.  Linking cell signaling and the epigenetic machinery.

Authors:  Helai P Mohammad; Stephen B Baylin
Journal:  Nat Biotechnol       Date:  2010-10       Impact factor: 54.908

6.  Histone demethylase RBP2 is critical for breast cancer progression and metastasis.

Authors:  Jian Cao; Zongzhi Liu; William K C Cheung; Minghui Zhao; Sophia Y Chen; Siew Wee Chan; Carmen J Booth; Don X Nguyen; Qin Yan
Journal:  Cell Rep       Date:  2014-02-27       Impact factor: 9.423

Review 7.  Developmental roles of the histone lysine demethylases.

Authors:  Amanda Nottke; Mónica P Colaiácovo; Yang Shi
Journal:  Development       Date:  2009-03       Impact factor: 6.868

Review 8.  Menin, histone h3 methyltransferases, and regulation of cell proliferation: current knowledge and perspective.

Authors:  Xinjiang Wu; Xianxin Hua
Journal:  Curr Mol Med       Date:  2008-12       Impact factor: 2.222

9.  Coordinated repression of cell cycle genes by KDM5A and E2F4 during differentiation.

Authors:  Michael L Beshiri; Katherine B Holmes; William F Richter; Samuel Hess; Abul B M M K Islam; Qin Yan; Lydia Plante; Larisa Litovchick; Nicolas Gévry; Nuria Lopez-Bigas; William G Kaelin; Elizaveta V Benevolenskaya
Journal:  Proc Natl Acad Sci U S A       Date:  2012-10-23       Impact factor: 11.205

Review 10.  Acquired Resistance to Drugs Targeting Tyrosine Kinases.

Authors:  Steven A Rosenzweig
Journal:  Adv Cancer Res       Date:  2018-03-02       Impact factor: 6.242

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.